SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,149,624 | -14.3% | 529,200 | -19.1% | 1.36% | +0.4% |
Q2 2023 | $74,896,080 | -42.2% | 654,000 | -30.4% | 1.36% | -46.7% |
Q1 2023 | $129,573,983 | +2.8% | 940,100 | -3.3% | 2.54% | +5.6% |
Q4 2022 | $125,990,634 | +24.1% | 972,300 | +5.9% | 2.41% | +27.9% |
Q3 2022 | $101,531,000 | +6673.2% | 918,500 | +4492.5% | 1.88% | +6881.5% |
Q2 2022 | $1,499,000 | -50.9% | 20,000 | -48.8% | 0.03% | -46.0% |
Q1 2022 | $3,054,000 | -42.2% | 39,100 | -33.4% | 0.05% | -26.5% |
Q4 2021 | $5,286,000 | -11.6% | 58,700 | -9.3% | 0.07% | +3.0% |
Q3 2021 | $5,983,000 | +18.9% | 64,700 | 0.0% | 0.07% | +29.4% |
Q2 2021 | $5,030,000 | -66.3% | 64,700 | -67.7% | 0.05% | -63.6% |
Q1 2021 | $14,927,000 | -85.1% | 200,278 | -66.0% | 0.14% | -84.1% |
Q4 2020 | $100,427,000 | +32.7% | 589,049 | +9.3% | 0.88% | -7.6% |
Q3 2020 | $75,699,000 | -15.6% | 539,049 | -3.7% | 0.95% | -24.7% |
Q2 2020 | $89,734,000 | +1.6% | 559,649 | -38.0% | 1.26% | -14.9% |
Q1 2020 | $88,278,000 | -10.7% | 902,449 | +17.8% | 1.48% | +5.2% |
Q4 2019 | $98,851,000 | +47.9% | 766,049 | -13.7% | 1.41% | +11.3% |
Q3 2019 | $66,835,000 | -46.9% | 887,349 | +7.1% | 1.27% | -34.9% |
Q2 2019 | $125,875,000 | +27.5% | 828,400 | 0.0% | 1.95% | +27.5% |
Q1 2019 | $98,737,000 | +15.8% | 828,400 | +6.1% | 1.53% | -3.0% |
Q4 2018 | $85,231,000 | -38.2% | 781,000 | -8.6% | 1.58% | -5.2% |
Q3 2018 | $137,994,000 | +130.7% | 854,400 | +88.8% | 1.66% | +132.8% |
Q2 2018 | $59,825,000 | +117.3% | 452,600 | +21.8% | 0.71% | +109.4% |
Q1 2018 | $27,532,000 | +231.2% | 371,600 | +148.7% | 0.34% | +224.8% |
Q4 2017 | $8,313,000 | +22.2% | 149,400 | -0.4% | 0.10% | +61.5% |
Q3 2017 | $6,804,000 | -78.2% | 150,000 | -85.8% | 0.06% | -81.6% |
Q1 2017 | $31,207,000 | +94.1% | 1,054,300 | +302.7% | 0.35% | +93.4% |
Q3 2016 | $16,077,000 | – | 261,800 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |